Maxolon and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is reported as a side effect among people who take Maxolon (metoclopramide hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Morphine, and have Constipation.

The phase IV clinical study analyzes which people have Intestinal obstruction when taking Maxolon. It is created by eHealthMe based on reports of 1,922 people who have side effects when taking Maxolon from the FDA, and is updated regularly.

What is Maxolon?

Maxolon has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 1,977 Maxolon users. Check the latest studies of Maxolon.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 1,887 drugs and 2,613 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.

On Jul, 11, 2026

1,922 people reported to have side effects when taking Maxolon.
Among them, 13 people (0.68%) have Intestinal obstruction.

Could Maxolon cause Intestinal obstruction?

Among these 13 people:

How long have people been on Maxolon when they have Intestinal obstruction? *

What is the gender of people who have Intestinal obstruction when taking Maxolon? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Intestinal obstruction when taking Maxolon? *

What are other drugs people take besides Maxolon? *

What are other side effects people have besides Intestinal obstruction? *

Abdominal Distension: 3 people, 23.08%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 23.08%
Leukopenia (less number of white blood cells in blood): 2 people, 15.38%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 15.38%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 15.38%
Eosinophil Count Increased: 2 people, 15.38%
Faeces Discolored: 2 people, 15.38%
Troponin Increased: 2 people, 15.38%
Gastrointestinal Perforation (hole in the digestive tract): 2 people, 15.38%
Blood Alkaline Phosphatase Increased: 2 people, 15.38%

What are the existing conditions these people have? *

Constipation: 5 people, 38.46%
Asthma: 3 people, 23.08%
Ovarian Cancer (cancer of ovary): 3 people, 23.08%
Urinary Tract Infection: 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 15.38%
Anaemia (lack of blood): 2 people, 15.38%
Blood Potassium Decreased: 2 people, 15.38%
Stress And Anxiety: 2 people, 15.38%
Abdominal Pain: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Maxolon and have Intestinal obstruction?

- Check whether Intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maxolon:

Maxolon (1,977 reports)

Browse all side effects of Maxolon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (1,887 drugs)

Browse all the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,613 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Maxolon) and Maxolon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.